The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy.
We studied inherent radiosensitivity/resistance (D0), ability to accumulate sublethal damage (n) and repair of potentially lethal damage (PLDR) in established human tumor cell lines as well as early passage human tumor cell lines derived from patients with known outcome following radiotherapy. Survival 24 hrs after treatment of human tumor cells with X rays in plateau phase cultures is a function of initial damage (D0, n), as well as recovery over 24 hrs (PLDR). A surviving fraction greater than .1 24 hrs following treatment with 7 Gy in plateau phase cultures is associated with tumor cell types (melanoma, osteosarcoma) with a high probability of radiotherapy failure or tumor cells derived from patients who actually failed radiotherapy. Therefore, total cellular recovery following radiation may be an important determinant or radiocurability. Accurate assays of radiotherapy outcome may need to account for all these radiobiological parameters.
D002460:Cell Line / Q000528:radiation effects; D002470:Cell Survival / Q000528:radiation effects; D004260:DNA Repair; D004273:DNA, Neoplasm / Q000528:radiation effects*; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011379:Prognosis; D011836:Radiation Tolerance
D004273:DNA, Neoplasm